Chelation-Assisted Carbon-Halide Bond ActiWation
PPh3), 138.06 (s), 143.77 (s), 144.11 (s), 150.10 (s), 158.06 (dt,
1JRh-C ) 26.8 Hz, 2JP-C ) 10.5 Hz, CRh), 163.61 (s). Anal. calcd
for C47H38IF6NP3Rh (1053.53): C, 53.58; H, 3.64; N, 1.33. Found:
C, 53.17; H, 3.86; N, 1.44.
C49H38Br2NP2Rh (965.49): C, 60.96; H, 3.97; N, 1.45. Found: C,
60.69; H, 4.01; N, 1.47.
Compound 4A-I2. To a suspension of rhodium hydride 3A (100
mg, 0.116 mmol) in THF was added I2 (50 mg, 0.231 mmol), and
the mixture was stirred at 0 °C for 4 h. The precipitate was then
filtered and was washed with 2 × 20 mL diethyl ether to give 4A-
I2 as an orange powder. Analytically pure 4A-I2 could be obtained
after recrystallization from the diffusion of diethyl ether into a
dilution of 4A-I2 in CH2Cl2. Yield: 87 mg (0.084 mmol, 73%). 1H
Complex 3A. To a suspension of [Rh(NBD)(PPh3)2]PF6 (500
mg, 0.578 mmol) in acetone (8 mL) was bubbled H2 for 15 min at
0 °C, during which time the color of the solution changed from
red to light yellow. tert-Butylethylene (0.8 mL) and benzo[h]quino-
line (124 mg, 0.694 mmol) were then added to the solution, and
the mixture was refluxed for 5 h. The solution was concentrated to
0.5 mL under reduced pressure. The residue was washed with
diethyl ether (2 × 20 mL) to give 3A as a white powder. Yield:
502 mg (0.497 mmol, 86%). 1H NMR (δ, 300 MHz, CD3COCD3,
295 K): -12.29 (dt, 1JRh-H ) 16.6 Hz, 2JP-H )11.0 Hz, 1H, RhH),
3
3
NMR (δ, 400 MHz, CD2Cl2, 298 K): 6.55 (dd, J ) 7.6 Hz, J )
5.8 Hz, 1H), 6.85 (t, 3J ) 7.6 Hz, 1H), 6.90-6.93 (m, 12H, PPh3),
7.10-7.16 (m, 18H, PPh3), 7.42 (d, J ) 8.7 Hz, 1H), 7.50 (d, J
) 7.9 Hz, 1H), 7.70 (d, J ) 7.7 Hz, 1H), 7.75 (d, J ) 7.9 Hz,
3
3
3
3
1H), 7.78 (d, J ) 8.8 Hz, 1H), 9.32 (d, J ) 5.5 Hz, 1H). 31P
{1H} NMR (δ, 162 MHz, CD2Cl2, 298 K): 11.98 (d, 1JRh-P ) 94.9
Hz, PPh3). No 13C NMR spectra could be obtained with an
acceptable signal-to-noise ratio due to the compound’s poor
solubility in common NMR solvents. Anal. calcd for C49H38I2NP2Rh
(1035.47): C, 55.55; H, 3.62; N, 1.32. Found: C, 55.53; H, 3.86;
N, 1.40.
3
3
3
2.06 (s, 6H, acetone), 6.96 (t, J ) 7.7 Hz, 1H), 7.05-7.38 [m,
32H, 2H (C13H8N) + 30H (PPh3)], 7.43 (d, 3J ) 7.7 Hz, 1H), 7.57
(d, 3J ) 8.8 Hz, 1H), 7.78 (dd, 3J ) 8.0 Hz, 3J ) 5.0 Hz, 1H), 8.16
(d, 3J ) 7.9 Hz, 1H), 9.79 (d, 3J ) 4.9 Hz, 1H). 31P {1H} NMR (δ,
1
121 MHz, CD3COCD3, 295 K): -143.56 (m, JF-P ) 704.0 Hz,
1
PF6), 39.91 (d, JRh-P ) 114.3 Hz, PPh3). 13C {1H} NMR (δ, 100
Compound 4B-I2. Complex 4B-I2 was synthesized by following
either the procedure for 4A-Br2 or that for 4A-I2. The reaction of
[Rh(NBD)(PPh3)2]PF6 (100 mg, 0.116 mmol) and 2-(2-iodophe-
nyl)pyridine (65 mg, 0.232 mmol) gave 4B-I2 as an orange powder.
Yield: 50 mg (0.049 mmol, 42%). 1H NMR (δ, 300 MHz, CD2Cl2,
MHz, CD3COCD3, 295 K): 120.52 (s), 122.44 (s), 122.83 (s),
126.83 (s), 127.31 (s), 128.08 (t, JP-C ) 4.7 Hz, PPh3), 128.60 (t,
1JP-C ) 23.0 Hz, ipso-PPh3), 130.30 (s, p-PPh3), 133.36 (t, JP-C
)
5.6 Hz, PPh3), 134.73 (s), 135.73 (s), 138.44 (s), 139.65 (s), 148.19
1
2
(s), 150.71 (s), 153.08 (dt, JRh-C ) 31.0 Hz, JP-C ) 11.2 Hz,
CRh), 205.26 (CO). Anal. calcd for C54H45F6NOP3Rh (1009.74):
C, 61.85; H, 4.49; N, 1.39. Found: C, 61.54; H, 4.95; N, 1.43.
Complex 3B. Complex 3B was obtained as a white powder by
directly following the synthesis of 3A. Yield: 428 mg (0.44 mmol,
3
3
298 K): 6.17 (t, J ) 6.0 Hz, 1H), 6.38 (t, J ) 8.0 Hz, 1H),
6.92-7.04 (m, 12H, PPh3), 7.13-7.25 [m, 9H, 6H (PPh3) + 3H
(C11H8N)], 7.35-7.44 [13H, 12H (PPh3) + 1H (C11H8N)], 7.53
(d, 3J ) 8.4 Hz, 1H), 9.16 (d, 3J ) 5.8 Hz, 1H). 31P {1H} NMR (δ,
162 MHz, CD2Cl2, 298 K): 12.23 (d, 1JRh-P ) 95.7 Hz, PPh3). No
13C NMR spectra could be obtained with an acceptable signal-to-
noise ratio due to the compound’s poor solubility in common NMR
solvents. Anal. calcd for C47H38I2NP2Rh (1035.47): C, 54.52; H,
3.70; N, 1.35. Found: C, 54.09; H, 4.04; N, 1.37.
1
87%). H NMR (δ, 300 MHz, CD3COCD3, 295 K): -12.26 (dt,
1
2
1H, JRh-H ) 15.6 Hz, JP-H )10.9 Hz, Rh-H), 2.06 (s, 6H,
acetone), 6.50 (t, 3J ) 6.7 Hz, 1H), 6.87 (t, 3J ) 7.6 Hz, 1H), 7.03
3
(d, J ) 7.7 Hz, 1H), 7.12-7.42 [m, 33H, 3H (C11H8N) + 30H
(PPh3)], 7.62 (t, J ) 6.8 Hz, 1H), 9.46 (d, J ) 5.5 Hz, 1H). 31P
3
3
Compound 4B-Br2. Complex 4B-Br2 could be synthesized by
directly following the procedure for the preparation of 4A-Br2. The
reaction of [Rh(NBD)(PPh3)2]PF6 (100 mg, 0.116 mmol) and 2-(2-
bromophenyl)pyridine (54 mg, 0.232 mmol) gave 4B-Br2 as a
{1H} NMR (δ, 121 MHz, CD3COCD3, 295 K): -143.58 (m, 1JF-P
) 705.1 Hz, PF6), 39.91 (d, JRh-P ) 115.8 Hz, PPh3). 13C {1H}
1
NMR (δ, 75 MHz, CD3CN, 295 K): 119.31 (s), 121.99 (s), 122.22
(s), 124.64 (s), 128.54 (s), 128.16 (t, JP-C ) 4.9 Hz, PPh3), 129.93
(t, 1JP-C ) 23.4 Hz, ipso-PPh3), 130.30 (s, p-PPh3), 133.39 (t, JP-C
) 5.8 Hz, PPh3), 136.85 (s), 142.10 (s), 144.03 (s), 149.33 (s),
161.69 (s), 159.56 (dt, 1JRh-C ) 28.4 Hz, 2JP-C ) 10.3 Hz, Rh-C),
206.45 (CO). Anal. calcd for C50H45F6NOP3Rh (985.72): C, 60.92;
H, 4.60; N, 1.42. Found: C, 60.52; H, 4.96; N, 1.51.
1
yellow powder. Yield: 41 mg (0.044 mmol, 38%). H NMR (δ,
300 MHz, CD2Cl2, 298 K): 6.17 (t, 3J ) 7.6 Hz, 1H), 6.41 (t, 3J )
7.3 Hz, 1H), 6.89 (t, 3J ) 7.2 Hz, 1H), 7.01-7.06 (m, 12H, PPh3),
7.16-7.21 [m, 7H, 6H (PPh3) + 1H (C11H8N)], 7.26-7.33 (m,
2H), 7.37-7.45 [13H, 12H (PPh3) + 1H (C11H8N)], 8.92 (d, 3J )
5.9 Hz, 1H). 31P {1H} NMR (δ, 121 MHz, CD2Cl2, 298 K): 13.66
(d, 1JRh-P ) 96.2 Hz, PPh3). No 13C NMR spectra could be obtained
with an acceptable signal-to-noise ratio due to the compound’s poor
solubility in common NMR solvents. Anal. calcd for
C47H38Br2NP2Rh (941.47): C, 59.96; H, 4.07; N, 1.49. Found: C,
59.99; H, 4.06; N, 1.39.
Compound 4A-Br2. To a suspension of [Rh(NBD)(PPh3)2]PF6
(100 mg, 0.116 mmol) in acetone (5 mL) was bubbled H2 for 15
min at 0 °C, during which time the color of the solution changed
from red to yellow. tert-Butylethylene (0.5 mL) and 10-bromoben-
zo[h]quinoline (60 mg, 0.231 mmol) were then added to the
solution, which was refluxed for 10 h. The precipitate was then
filtered and washed with acetone, cold CH2Cl2, and then diethyl
ether to give 4A-Br2 as a yellow powder. Yield: 45.6 mg (0.047
mmol, 41%). 1H NMR (δ, 400 MHz, CD2Cl2, 298 K): 6.53 (dd, 3J
) 8.0 Hz, 3J ) 5.7 Hz, 1H), 6.87 (t, 3J ) 7.5 Hz, 1H), 6.94-6.97
Compound 6. Iridium hydride 5 was synthesized by following
a literature report.20a To a suspension of 5 (100 mg, 0.091 mmol)
in THF was added I2 (46 mg, 0.182 mmol), and the mixture was
stirred at 0 °C for 4 h. The precipitate was then filtered and was
washed with diethyl ether (2 × 20 mL) to give 6 as a yellow
powder. Yield: 88 mg (0.077 mmol, 85%). 1H NMR (δ, 400 MHz,
CD2Cl2, 298 K): 6.52 (dd, 3J ) 7.7 Hz, 3J ) 5.8 Hz, 1H), 6.89 (t,
3J ) 7.8 Hz, 1H), 6.93-6.97 (m, 12H, PPh3), 7.14-7.17 (m, 18H,
3
(m, 12H, PPh3), 7.14 (t, J ) 7.4 Hz, 6H, PPh3), 7.19-7.24 (m,
12H, PPh3), 7.41 (d, 3J ) 8.4 Hz, 2H), 7.56 (d, 3J ) 7.7 Hz, 1H),
7.69 (d, 3J ) 8.0 Hz, 1H), 7.74 (d, 3J ) 8.7 Hz, 1H), 9.02 (d, 3J )
5.4 Hz, 1H). 31P {1H} NMR (δ, 162 MHz, CD3CN, 298 K): 13.25
(d, 1JRh-P ) 96.9 Hz, PPh3). No 13C NMR spectra could be obtained
with an acceptable signal-to-noise ratio due to the compound’s poor
solubility in common NMR solvents. Single crystals of 4A-Br2
could be obtained by the diffusion of diethyl ether into a dilute
solution of 4A-Br2 in CH2Cl2 or MeCN. Anal. calcd for
3
3
PPh3), 7.41 (d, J ) 8.7 Hz, 1H), 7.49 (d, J ) 7.7 Hz, 1H), 7.62
(m, 2H), 7.80 (d, 3J ) 8.7 Hz, 1H), 9.26 (d, 3J ) 5.6 Hz, 1H). 31
P
{1H} NMR (δ, 162 MHz, CD2Cl2, 298 K): -26.54 (s, PPh3). 13C
{1H} NMR (δ, 100 MHz, CD2Cl2, 298 K): 120.14 (s), 122.04 (s),
122.92 (s), 126.38 (s), 126.68 (t, JP-C ) 4.8 Hz, PPh3), 128.77 (s),
129.25 (s, p-PPh3), 130.63 (t, 1JP-C ) 26.7 Hz, ipso-PPh3), 131.19
Inorganic Chemistry, Vol. 48, No. 3, 2009 1205